CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bausch Health Companies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bausch Health Companies Inc
2150 Saint-Elzear Blvd W
Phone: (514) 744-6792p:514 744-6792 LAVAL, QC  H7L 4A8  Canada Ticker: BHCBHC

Business Summary
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-YesYes--

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201912/31/2018Yes--YesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer Joseph C.Papa 63 5/2/2016 5/2/2016
Chief Financial Officer, Executive Vice President Paul S.Herendeen 63 8/22/2016 8/22/2016
President & Co-Head Bausch + Lomb/International Thomas J.Appio 57 8/1/2018 4/1/2016
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Valeant Pharmaceuticals Ireland Limited 3013 Citywest Business Campus Dublin Ireland
Jelfa S.A. 21 Wincentego Pola Str. Jelenia Gora Poland
Sanitas AB Veiveriu str. 134B KAUNAS Lithuania
23 additional Subsidiary records available in full report.

Business Names
Business Name
0909657 B.C. Ltd.
0919837 B.C. Ltd.
0938638 B.C. Ltd.
321 additional Business Names available in full report.

General Information
Number of Employees: 21,100 (As of 12/31/2018)
Outstanding Shares: 352,431,217 (As of 10/31/2019)
Shareholders: 1,885
Stock Exchange: TSE
Fax Number: (514) 744-6272


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 15, 2019